source
- Novo Nordisk leads early in oral obesity market, but analysts doubt lasting advantageNovo Nordisk's oral formulation of Wegovy generated DKK 3.22 billion (about $496 million) in revenue in the second quarter of 2026, far outpacing Eli Lilly's newly approved oral weight‑loss pill Fo…
- Trump administration eyes Heidi Overton as next FDA commissionerPresident Donald Trump is reported to be preparing a nomination for Heidi Overton to become the next commissioner of the Food and Drug Administration, according to multiple news outlets. Overton i…